Thoughts on promoting the industrialization of stem cells: From the perspective of medical institutions and enterprises
10.3760/cma.j.cn113565-20200514-00157
- VernacularTitle:关于推进干细胞产业化的思考
- Author:
Hongming TANG
1
;
Qinghui ZHAO
;
Bin HE
;
Erpeng JIANG
;
Zhongmin LIU
Author Information
1. 同济大学附属东方医院干细胞转化医学产业基地 国家干细胞转化资源库 上海干细胞临床转化研究院 上海市干细胞临床诊疗工程研究中心 200123
- Keywords:
Stem cells;
Stem cell and translational research;
Stem cell industry;
Medical institutions
- From:
Chinese Journal of Medical Science Research Management
2021;34(1):46-50
- CountryChina
- Language:Chinese
-
Abstract:
Objective:From the perspective of medical institutions and enterprises, based on the current situation in China, starting from the breakthrough the bottleneck of industrial development, discuss possible measures to promote the industrialization of stem cells.Methods:The factors that affect the stem cell industrialization were studied by sorting and analyzing the current stem cell industrialization policy and environment, current situation and existing problems, etc.Results:From the perspective of medical institutions and enterprises, combined with the connotation and characteristics of the stem cell industry and the author's experience and practice during the past 10 years, it is recommended to consider the promotion of the industrialization of stem cells comprehensively from the three levels that including " three transformations" , " three doubles" and " three integrations" .Conclusions:Integrate and play the role of medical institutions as the main body of stem cell clinical research and enterprises as the main body of stem cell industrialization, strengthen the multi-stakeholder cooperation among government, industry, academia, research and funding agencies, accelerate the development, transformation and application of stem cell products and derivative products.Promoting the coordinated development of the upstream, midstream, downstream and related supporting industries of the stem cell industry is of great practical significance for seizing a new round of industrial translation and historical development opportunities in the biomedical field, seizing the commanding heights of the international stem cell industry, and helping the country's major development strategy.
